3.
Relation of galactin-3 expression to other clinicopathological variables
| Variables | Galectin-3 expression, n (%) | χ2 | P | |||
| 0 | + | ++ | +++ | |||
| Age, years | 1.636 | 0.651 | ||||
| <30 | 0 | 10 (45.5) | 9 (40.9) | 3 (13.6) | ||
| >30 | 6 (4.5) | 63 (48.1) | 41 (31.2) | 21 (16.2) | ||
| Gender | 3.846 | 0.279 | ||||
| Female | 6 (5.3) | 54 (47.7) | 38 (33.6) | 15 (13.2) | ||
| Male | 0 | 19 (47.5) | 12 (3) | 9 (22.5) | ||
| Location | 6.396 | 0.380 | ||||
| Hemispheric | 3 (3.0) | 42 (42.4) | 36 (36.4) | 18 (18.2) | ||
| Skull base | 3 (7.5) | 22 (55.0) | 10 (25.0) | 5 (12.5) | ||
| Spinal | 0 | 9 (64.2) | 4 (28.5) | 1 (7.1) | ||
| Histologic type | 90.118 | <0.001 | ||||
| Transitional | 2 (3.3) | 14 (23.3) | 32 (53.3) | 12 (20.0) | ||
| Meningotheliomatous | 1 (2.5) | 34 (82.9) | 5 (12.2) | 1 (2.4) | ||
| Psammomatous | 2 (66.6) | 1 (33.3) | 0 | 0 | ||
| Fibroblastic | 1 (9.1) | 9 (81.8) | 1 (9.1) | 0 | ||
| Atypical | 0 | 0 | 10 (55.6) | 8 (44.4) | ||
| Microcystic | 0 | 3 (100) | 0 | 0 | ||
| Metaplastic | 0 | 1 (50) | 0 | 1 (50.0) | ||
| Angiomatous | 0 | 2 (66.7) | 0 | 1 (33.3) | ||
| Malignant | 0 | 2 (66.7) | 0 | 1 (33.3) | ||
| Histologic grade | 35.823 | <0.001 | ||||
| Grade 1 | 6 (4.6) | 73 (55.7) | 39 (29.8) | 13 (9.9) | ||
| Grade 2 | 0 | 0 | 9 (47.3) | 10 (52.6) | ||
| Grade 3 | 0 | 0 | 2 (66.6) | 1 (33.4) | ||
| Recurrence | 35.618 | <0.001 | ||||
| No | 6 (4.5) | 73 (54.8) | 41 (30.8) | 13 (9.7) | ||
| Yes | 0 | 0 | 9 (45.0) | 11 (55.0) | ||
| Brain invasion | 39.384 | <0.001 | ||||
| No | 6 (4.6) | 73 (55.7) | 39 (29.8) | 13 (9.9) | ||
| Yes | 0 (0) | 0 (0) | 11 (50.0) | 11 (50.0) | ||